Top

JA Clinical Reports

Published in:

Open Access 01-12-2024 | Sevoflurane | Case report

Sustained mitigation of ST-segment elevation in a patient with Brugada syndrome type 1 during sevoflurane and remifentanil anesthesia: a case report

Authors: Kurumi Saito, Hitoshi Yoshida, Kazuyoshi Hirota

Published in: JA Clinical Reports | Issue 1/2024

Abstract

Background

During general anesthesia, patients with Brugada syndrome are at risk of malignant arrhythmias following worsened ST-segment elevation, potentially leading to sudden cardiac death. The protocol for safe anesthetic management of patients with Brugada syndrome has not yet been established.

Case presentation

A 63-year-old man, diagnosed with a spontaneous Brugada type 1 pattern, was scheduled for a pleural biopsy using video-assisted thoracoscopic surgery under general anesthesia. We planned general anesthesia using volatile induction and maintenance anesthesia with sevoflurane and remifentanil. We monitored ST-segment morphology and observed sustained mitigation of ST-segment elevation throughout general anesthesia.

Conclusion

The present case may indicate that safe anesthetic management of patients with Brugada syndrome depends on whether the anesthetics used can reduce ST-segment elevation.

Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome A multicenter report. J Am Coll Cardiol. 1992;20:1391–6.CrossRefPubMed

Kloesel B, Ackerman MJ, Sprung J, Narr BJ, Weingarten TN. Anesthetic management of patients with Brugada syndrome: a case series and literature review. Can J Anaesth. 2011;58:824–36.CrossRefPubMed

Blok M, Boukens BJ. Mechanisms of arrhythmias in the Brugada syndrome. Int J Mol Sci. 2020;21:7051.CrossRefPubMedPubMedCentral

Krahn AD, Behr ER, Hamilton R, Probst V, Laksman Z, Han HC. Brugada syndrome JACC Clin Electrophysiol. 2022;8:386–405.CrossRefPubMed

Brugada J, Brugada P, Brugada R. The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death - the Brugada syndrome. Europace. 1999;1:156–66.CrossRefPubMed

Espinosa Á, Ripollés-Melchor J, Brugada R, Campuzano Ó, Sarquella-Brugada G, Abad-Motos A, et al. Brugada syndrome: anesthetic considerations and management algorithm. Minerva Anestesiol. 2019;85:173–88.CrossRefPubMed

Flamée P, Viaene K, Tosi M, Nogueria Carvalho H, Asmundis C, Forget P, et al. Propofol for induction and maintenance of anesthesia in patients with Brugada syndrome: a single-center, 25-year, retrospective cohort analysis. Anesth Analg. 2021;132:1645–53.CrossRefPubMed

Ciconte G, Santinelli V, Brugada J, Vicedomini G, Conti M, Monasky MM, et al. General anesthesia attenuates Brugada syndrome phenotype expression: clinical implications from a prospective clinical trial. JACC Clin Electrophysiol. 2018;4:518–30.CrossRefPubMed

Flamée P, Varnavas V, Dewals W, Carvalho H, Cools W, Bhutia JT, et al. Electrocardiographic effects of propofol versus etomidate in patients with Brugada syndrome. Anesthesiology. 2020;132:440–51.CrossRefPubMed

10.

Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10:1932–63.CrossRefPubMed

11.

Di Diego JM, Cordeiro JM, Goodrow RJ, Fish JM, Zygmunt AC, Pérez GJ, et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation. 2002;106:2004–11.CrossRefPubMed

12.

Niwa N, Nerbonne JM. Molecular determinants of cardiac transient outward potassium current (I_to) expression and regulation. J Mol Cell Cardiol. 2010;48:12–25.CrossRefPubMed

13.

Shimizu W, Aiba T, Kamakura S. Mechanisms of disease: current understanding and future challenges in Brugada syndrome. Nat Clin Pract Cardiovasc Med. 2005;2:408–14.CrossRefPubMed

14.

Kang J, Reynolds WP, Chen X-L, Ji J, Wang H, Rampe DE. Mechanisms underlying the QT interval-prolonging effects of sevoflurane and its interactions with other QT-prolonging drugs. Anesthesiology. 2006;104:1015–22.CrossRefPubMed

Title: Sustained mitigation of ST-segment elevation in a patient with Brugada syndrome type 1 during sevoflurane and remifentanil anesthesia: a case report
Authors: Kurumi Saito
Hitoshi Yoshida
Kazuyoshi Hirota
Publication date: 01-12-2024
Publisher: Springer Berlin Heidelberg
Keywords: Sevoflurane
Remifentanil
Anesthetics
Anesthetics
Propofol
General Anesthesia
Published in: JA Clinical Reports / Issue 1/2024
Electronic ISSN: 2363-9024
DOI: https://doi.org/10.1186/s40981-024-00702-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Sustained mitigation of ST-segment elevation in a patient with Brugada syndrome type 1 during sevoflurane and remifentanil anesthesia: a case report

Abstract

Background

Case presentation

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2024

Amino acids to prevent cardiac surgery-associated acute kidney injury: a randomized controlled trial

Stroke volume variation remains accurate in the presence of proximal stenosis

A retrospective study of the prevalence of isolated prolongation of activated partial thromboplastin time in the preoperative setting

Anesthetic management in pregnant women with Fontan circulation: a case series

Perioperative anaphylaxis with no identifiable cause

Vulnerability to bending and occlusion of distal lumen of the 17G triple-lumen central venous catheter